The expression of GNA15 in AML was significantly higher than healthy volunteers and ALL in our cohort (median 810.00%, range [67.87%-6630.48%] vs 209.15% range [0-1073.74%], P<0.0001; 810.00%, range [67.87%-6630.48%] vs 520.55% range [13.64%-5205.27%], P=0.0003; Figure 1D). Here, GNA15 is linked to acute myeloid leukemia.